Literature DB >> 7814535

Concordance of endotoxemia with gram-negative bacteremia in patients with gram-negative sepsis: a meta-analysis.

J C Hurley1.   

Abstract

The Limulus amebocyte lysate (LAL) assay is a sensitive method for detecting endotoxin. Using gram-negative (GN) bacteremia as the basis for comparison, concordance with endotoxemia in 45 studies could be expressed as an odds ratio. Calculation of summary odds ratios by the Mantel-Haenszel-Peto method indicated that the concordance of the results was no higher by the chromogenic LAL assay than by the gelation version, and the sensitivity was improved by only 11% (62 versus 51%). Endotoxemia was detected in 77 (68%) of 114 patients with bacteremia caused by an organism that was not a member of the family Enterobacteriaceae, whereas endotoxemia was detected in only 120 (45%) of 269 patients with bacteremia caused by a member of the family Enterobacteriaceae or an anaerobe (P < 0.001). This difference was also apparent for patients with GN bacteremia for whom a fatal outcome had been recorded. The prevalence of GN bacteremia in the tested population and the type of etiological agent are critical and previously unrecognized variables which affect the interpretation of the LAL test in patients with suspected sepsis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814535      PMCID: PMC263953          DOI: 10.1128/jcm.32.9.2120-2127.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  73 in total

1.  Have you ever meta-analysis you didn't like?

Authors:  S N Goodman
Journal:  Ann Intern Med       Date:  1991-02-01       Impact factor: 25.391

2.  Clinical experience on the detection of endotoxemia with the limulus test.

Authors:  L A Martinez; R Quintiliani; R C Tilton
Journal:  J Infect Dis       Date:  1973-01       Impact factor: 5.226

3.  Diagnostic and prognostic significance of plasma endotoxin determination in febrile patients with haematological malignancies.

Authors:  M Yoshida; T Obayashi; H Tamura; S Tanaka; T Kawai; S Sakamoto; Y Miura
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

4.  An improved chromogenic substrate endotoxin assay for clinical use.

Authors:  R I Harris; P C Stone; J Stuart
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

5.  Clinical utility of the Limulus amebocyte lysate (LAL) test.

Authors:  R J Elin; J Hosseini
Journal:  Prog Clin Biol Res       Date:  1985

6.  Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock.

Authors:  R L Danner; C Natanson; R J Elin; J M Hosseini; S Banks; T J MacVittie; J E Parrillo
Journal:  Chest       Date:  1990-12       Impact factor: 9.410

7.  Host metabolites that phenotypically increase the resistance of Haemophilus influenzae type b to clearance mechanisms.

Authors:  M Kuratana; P Anderson
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

8.  Tachypleus lysate test for endotoxin in patients with Gram negative bacterial infections.

Authors:  W Usawattanakul; S Tharavanij; A Limsuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  1979-03       Impact factor: 0.267

9.  Endotoxin, bile salts and renal function in obstructive jaundice.

Authors:  M E Bailey
Journal:  Br J Surg       Date:  1976-10       Impact factor: 6.939

10.  Endotoxemia in protein-energy malnutrition.

Authors:  K Klein; G J Fuchs; P Kulapongs; G Mertz; R M Suskind; R E Olson
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Mar-Apr       Impact factor: 2.839

View more
  15 in total

1.  A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia.

Authors:  Claudia Guida; Sandro Altamura; Felix A Klein; Bruno Galy; Michael Boutros; Artur J Ulmer; Matthias W Hentze; Martina U Muckenthaler
Journal:  Blood       Date:  2015-02-06       Impact factor: 22.113

2.  N-formyl-methionyl-leucyl-phenylalanine (fMLP) inhibits tumour necrosis factor-alpha (TNF-alpha) production on lipopolysaccharide (LPS)-stimulated human neutrophils.

Authors:  M Vulcano; M F Alves Rosa; F S Minnucci; A C Cherñavsky; M A Isturiz
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

3.  Bactericidal/permeability-increasing protein preserves leukocyte functions after major liver resection.

Authors:  M J Wiezer; C Meijer; C Sietses; H A Prins; M A Cuesta; R H Beelen; S Meijer; P A van Leeuwen
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

4.  Reappraisal with meta-analysis of bacteremia, endotoxemia, and mortality in gram-negative sepsis.

Authors:  J C Hurley
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

Review 5.  Antibiotic-induced release of endotoxin. A therapeutic paradox.

Authors:  J C Hurley
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

6.  Prophylaxis with enteral antibiotics in ventilated patients: selective decontamination or selective cross-infection?

Authors:  J C Hurley
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

7.  A Flowthrough Assay for Rapid Bedside Stratification of Bloodstream Bacterial Infection in Critically Ill Patients: a Pilot Study.

Authors:  Pramod Jagtap; Rohini Singh; Karuna Deepika; Venkataraman Sritharan; Shalini Gupta
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

8.  Concordance of bacterial cultures with endotoxin and interleukin-6 in necrotizing enterocolitis.

Authors:  L C Duffy; M A Zielezny; V Carrion; E Griffiths; D Dryja; M Hilty; C Rook; F Morin
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

9.  Does gram-negative bacteraemia occur without endotoxaemia? A meta-analysis using hierarchical summary ROC curves.

Authors:  J C Hurley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-29       Impact factor: 3.267

10.  Can Enterococcal Infections Initiate Sepsis Syndrome?

Authors:  Peter Linden
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.